Converge Bio
Wilmington · Founded 2024
About Converge Bio
Converge Bio integrates Generative AI with biological data. Converge Bio mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
Company Facts
- Founded: 2024
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $30.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2026)
- Website: https://converge-bio.com/
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/converge-bio-1568 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.